The survey also found that flexible and virtual appointments, as well as transportation support, were helpful while on ...

Large PBMs are removing Humira from some of their formularies. AMCP Nexus panelist still see challenges a need for education ...

Large PBMs are removing Humira from some of their formularies. AMCP Nexus panelist still see challenges a need for education ...

What’s more, AM-101 improved radiation treatment, slowing down the growth of NSCLC subcutaneous xenograft tumors in mice, by ...

The Centers for Disease Control and Prevention provides funding for HIV prevention for the populations at the highest risk of ...

Several companies are developing new drugs treat transthyretin amyloidosis cardiomyopathy (ATTR-CM), an formerly obscure ...

Crescent Moore, Ph.D., Pharm.D., Director of Part D/Pharmacy at BluePeak Advisors, highlights the expected shift of Medicare ...

Crescent Moore, Ph.D., Pharm.D., Director of Part D/Pharmacy at BluePeak Advisors, explains the impacts of the upcoming ...

Charlie Dragovich, Senior Director and Client Strategist at Cencora, talks about the way regulations usually work and how the ...

Only a small group of patients have started the process to receive the new gene therapies for sickle cell disease, says Kevin ...

Two years after treatment, both girls show normal motor function and no signs of spinal muscular atrophy symptoms.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...